Stockscreener 앱 받기
7.32
0.14%
0.01
시간 외 거래:
7.32
전일 마감가:
$7.31
열려 있는:
$7.48
하루 거래량:
290.83K
Relative Volume:
0.88
시가총액:
$644.23M
수익:
-
순이익/손실:
$-42.63M
주가수익비율:
-13.86
EPS:
-0.5281
순현금흐름:
$-39.43M
1주 성능:
+5.02%
1개월 성능:
+1.10%
6개월 성능:
+78.97%
1년 성능:
+181.54%
1일 변동 폭
$7.10
$7.52
1주일 범위
$6.96
$7.70
52주 변동 폭
$2.30
$8.60
Alpha Tau Medical Ltd Stock (DRTS) Company Profile
Compare DRTS vs VRTX, REGN, ARGX, ALNY, ONC
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
DRTS
Alpha Tau Medical Ltd
|
7.32 | 643.35M | 0 | -42.63M | -39.43M | -0.5281 |
|
VRTX
Vertex Pharmaceuticals Inc
|
458.05 | 114.72B | 12.07B | 3.95B | 3.19B | 15.33 |
|
REGN
Regeneron Pharmaceuticals Inc
|
737.45 | 78.67B | 14.34B | 4.50B | 3.77B | 41.56 |
|
ARGX
Argen X Se Adr
|
684.50 | 42.38B | 4.16B | 1.29B | 734.26M | 19.59 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
311.10 | 41.75B | 3.71B | 313.75M | 465.38M | 2.2571 |
|
ONC
Beone Medicines Ltd Adr
|
282.72 | 31.33B | 5.36B | 287.73M | 924.18M | 2.5229 |
Alpha Tau Medical Ltd Stock (DRTS) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2026-03-04 | 다운그레이드 | Piper Sandler | Overweight → Neutral |
| 2023-12-15 | 개시 | Citigroup | Buy |
| 2023-04-24 | 개시 | H.C. Wainwright | Buy |
| 2022-04-14 | 개시 | Cantor Fitzgerald | Overweight |
| 2022-04-08 | 개시 | Piper Sandler | Overweight |
| 2022-04-04 | 개시 | Citigroup | Buy |
모두보기
Alpha Tau Medical Ltd 주식(DRTS)의 최신 뉴스
Alpha Tau Medical (NASDAQ:DRTS) Shares Gap UpHere's Why - MarketBeat
Alpha Tau Medical Conference: Japan Approval, Rolling FDA PMA, and Big 2026 Data Readouts Teased - Yahoo Finance
Resistance Check: Is Alpha Tau Medical Ltd Equity Warrant benefiting from interest rate changesRate Hike & Daily Volume Surge Signals - baoquankhu1.vn
Alpha Tau Medical (DRTS) director details shares, options and RSUs - Stock Titan
Alpha Tau (DRTS) director discloses initial shares, RSUs and options - Stock Titan
Alpha Tau Medical (NASDAQ: DRTS) CEO details equity holdings - Stock Titan
Alpha Tau Medical (DRTS) director Alan Adler details share and option holdings - Stock Titan
Alpha Tau Medical (DRTS) director discloses shares, RSUs and options - Stock Titan
Alpha Tau Medical (DRTS) director details shares, options and warrants - Stock Titan
Alpha Tau Medical (NASDAQ: DRTS) director discloses initial shares, RSUs and option grants - Stock Titan
Alpha Tau Medical (NASDAQ: DRTS) director details initial equity holdings - Stock Titan
Alpha Tau Medical (DRTS) CFO Raphi Levy reports detailed insider holdings - Stock Titan
Pullback Watch: Can Alpha Tau Medical Ltd Equity Warrant reach all time highs this year2026 Top Gainers & Safe Swing Trade Setups - baoquankhu1.vn
Aug EndMonth: Will Alpha Tau Medical Ltd Equity Warrant benefit from rising consumer demandPortfolio Gains Report & Short-Term Trading Opportunity Alerts - baoquankhu1.vn
Is Alpha Tau Medical Ltd stock showing strong momentum2026 Spike Watch & High Accuracy Swing Entry Alerts - baoquankhu1.vn
Market Recap: Is Alpha Tau Medical Ltd Equity Warrant stock overvalued or fairly priced2026 Trading Volume Trends & Weekly Stock Breakout Alerts - baoquankhu1.vn
CFO Raphi Levy to pitch Alpha Tau to investors at Sidoti event this week - Stock Titan
Citigroup maintains Alpha Tau Medical (DRTS) buy recommendation - MSN
Alpha Tau Medical to Present at Sidoti March Virtual Small Cap Conference - geneonline.com
Piper Sandler cuts Alpha Tau Medical stock rating on valuation By Investing.com - Investing.com Nigeria
Alpha Tau Medical’s innovative prostate cancer therapy: study completion update - MSN
Fund Flows: What is the PEG ratio of Alpha Tau Medical Ltd2026 Institutional Moves & Low Risk Entry Point Tips - baoquankhu1.vn
Citigroup Forecasts Strong Price Appreciation for Alpha Tau Medical (NASDAQ:DRTS) Stock - Defense World
HC Wainwright Has Negative Estimate for DRTS Q1 Earnings - Defense World
Short Squeeze: Will Alpha Tau Medical Ltd benefit from rate cuts2026 Fundamental Recap & Low Drawdown Momentum Ideas - baoquankhu1.vn
HC Wainwright Issues Pessimistic Estimate for DRTS Earnings - MarketBeat
Citigroup Increases Alpha Tau Medical (NASDAQ:DRTS) Price Target to $9.00 - MarketBeat
Alpha Tau Medical (NASDAQ:DRTS) Given Buy Rating at HC Wainwright - Defense World
HC Wainwright Reaffirms "Buy" Rating for Alpha Tau Medical (NASDAQ:DRTS) - MarketBeat
Alpha Tau Medical: U.S. Trial Expansion, Japan Approval, and Manufacturing Scale-Up Support Buy Rating Despite Near-Term Losses - TipRanks
Alpha Tau Medical (NASDAQ:DRTS) Issues Earnings Results, Misses Estimates By $0.01 EPS - MarketBeat
DRTS: Alpha DaRT shows promising efficacy in solid tumors, with pivotal trials and global expansion ongoing - TradingView
Alpha Tau Posts Wider 2025 Loss as Japanese Approval and U.S. Trial Progress Mark Pivotal Year - TipRanks
Alpha Tau Medical (NASDAQ: DRTS) outlines 2025 loss and Oramed financing - Stock Titan
Alpha Tau (NASDAQ: DRTS) widens 2025 loss but gains Japan approval, $76.9M cash - Stock Titan
Alpha Tau Medical Ltd. Reports Earnings Results for the Full Year Ended December 31, 2025 - marketscreener.com
Alpha Tau cancer therapy wins Japan nod, targets tough tumors - Stock Titan
Trade Report: Is Alpha Tau Medical Ltd Equity Warrant stock a good pick for beginners2026 Volatility Report & AI Enhanced Trading Alerts - baoquankhu1.vn
Is Alpha Tau Medical Ltd. Equity Warrant benefiting from interest rate changesPortfolio Value Summary & Growth-Oriented Investment Plans - mfd.ru
Alpha Tau Medical Ltd. (NASDAQ:DRTS) Receives $7.00 Average PT from Analysts - Defense World
Piper Sandler Reaffirms Neutral Rating for Alpha Tau Medical (NASDAQ:DRTS) - Defense World
Alpha Tau Medical Shares Fall After Piper Sandler Downgrade - marketscreener.com
Piper Sandler cuts Alpha Tau Medical stock rating on valuation - Investing.com South Africa
DRTS Receives Downgrade from Piper Sandler with Neutral Rating | - GuruFocus
Alpha Tau Medical Ltd. (NASDAQ:DRTS) Receives Consensus Rating of "Hold" from Brokerages - MarketBeat
Piper Sandler Reiterates Neutral Rating for Alpha Tau Medical (NASDAQ:DRTS) - MarketBeat
Alpha Tau Medical (DRTS) Expected to Announce Quarterly Earnings on Wednesday - MarketBeat
DRTS Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Alpha Tau Medical Ltd. (DRTS) Stock Analysis: Exploring a 6.89% Upside in Innovative Cancer Treatment Technology - DirectorsTalk Interviews
DRTS (NASDAQ: DRTS) Oppenheimer-listed 10,000‑share Form 144 notice - Stock Titan
Alpha Tau Medical (DRTSW) to Release Earnings on Thursday - Defense World
Alpha Tau Medical Ltd (DRTS) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.20%
0.06%
자본화:
|
볼륨(24시간):